Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Roche patent divulges novel K(Ca)3.1 channel blockers

June 4, 2014

Dosing under way in phase IIa study of LPCN-1111 in hypogonadal men

May 30, 2014

U.S. investigators report development of HDAC inhibitors for AKI

May 29, 2014

FDA extends Zerenex PDUFA goal date

May 23, 2014

Ardelyx receives milestone payment for initiation of phase tenapanor trial

May 16, 2014

Mitochondrial genes delivered in vivo confer protection against renal I/R injury

May 5, 2014

Allena Pharmaceuticals reports phase I data for ALLN-177

May 2, 2014

PAR-1 antagonist F-16357 dose-dependently inhibits bladder contraction

April 28, 2014

New bicyclic derivatives synthesized by Roche

April 25, 2014

Torii Pharmaceutical set to launch Riona in Japan for the treatment of hyperphosphatemia

April 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...